Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Effron

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
European Heart Journal|January 22, 2011
A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 TrialDominick J Angiolillo, Juan Jose Badimon, Jorge F Saucedo, et al.
Circulation|May 22, 2015
Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial Infarction: Insights From the Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) StudyYing Xian, Tracy Y Wang, Lisa A McCoy, et al.
JAMA Cardiology|May 25, 2017
Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS StudyPatricia O Guimarães, Arun Krishnamoorthy, Lisa A Kaltenbach, et al.
JAMA Cardiology|July 21, 2016
Comparing Inverse Probability of Treatment Weighting and Instrumental Variable Methods for the Evaluation of Adenosine Diphosphate Receptor Inhibitors After Percutaneous Coronary InterventionJerome J Federspiel, Kevin J Anstrom, Ying Xian, et al.
American Heart Journal|December 17, 2016
Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational studyMarjorie E Zettler, Eric D Peterson, Lisa A McCoy, et al.
JACC. Cardiovascular Interventions|October 24, 2009
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitalsHoward C Herrmann, Jiandong Lu, Bruce R Brodie, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 10, 2017
One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims DatabaseMark B Effron, Kavita V Nair, Cliff Molife, et al.
Circulation. Cardiovascular Interventions|October 30, 2016
Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome)Emil L Fosbøl, Christine Ju, Kevin J Anstrom, et al.
Journal of the American Heart Association|October 30, 2016
Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) StudyLarry R Jackson, Eric D Peterson, Lisa A McCoy, et al.
American Heart Journal|April 30, 2017
Association of measured platelet reactivity with changes in P2Y<sub>12</sub> receptor inhibitor therapy and outcomes after myocardial infarction: Insights into routine clinical practice from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) studyAkshay Bagai, Eric D Peterson, Lisa A McCoy, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
European Heart Journal|January 22, 2011
A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 TrialDominick J Angiolillo, Juan Jose Badimon, Jorge F Saucedo, et al.
Circulation|May 22, 2015
Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial Infarction: Insights From the Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) StudyYing Xian, Tracy Y Wang, Lisa A McCoy, et al.
JAMA Cardiology|May 25, 2017
Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS StudyPatricia O Guimarães, Arun Krishnamoorthy, Lisa A Kaltenbach, et al.
JAMA Cardiology|July 21, 2016
Comparing Inverse Probability of Treatment Weighting and Instrumental Variable Methods for the Evaluation of Adenosine Diphosphate Receptor Inhibitors After Percutaneous Coronary InterventionJerome J Federspiel, Kevin J Anstrom, Ying Xian, et al.
American Heart Journal|December 17, 2016
Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational studyMarjorie E Zettler, Eric D Peterson, Lisa A McCoy, et al.
JACC. Cardiovascular Interventions|October 24, 2009
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitalsHoward C Herrmann, Jiandong Lu, Bruce R Brodie, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 10, 2017
One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims DatabaseMark B Effron, Kavita V Nair, Cliff Molife, et al.
Circulation. Cardiovascular Interventions|October 30, 2016
Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome)Emil L Fosbøl, Christine Ju, Kevin J Anstrom, et al.
Journal of the American Heart Association|October 30, 2016
Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) StudyLarry R Jackson, Eric D Peterson, Lisa A McCoy, et al.
American Heart Journal|April 30, 2017
Association of measured platelet reactivity with changes in P2Y<sub>12</sub> receptor inhibitor therapy and outcomes after myocardial infarction: Insights into routine clinical practice from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) studyAkshay Bagai, Eric D Peterson, Lisa A McCoy, et al.
Pageof 10